Literature DB >> 19890702

Membrane saturated fatty acids and disease progression in multiple sclerosis patients.

G M Hon1, M S Hassan, S J van Rensburg, S Abel, R T Erasmus, T Matsha.   

Abstract

The risk of developing multiple sclerosis is associated with increased dietary intake of saturated fatty acids. We determined the fatty acid composition within the different phospholipid fractions of red blood and peripheral blood mononuclear cell membranes of 31 patients diagnosed with multiple sclerosis and 30 healthy control subjects using gas chromatography. Individual saturated fatty acids were correlated with the severity of neurological outcome as measured by the Kurtzke Expanded Disability Status Scale. Significant increases were found in multiple sclerosis peripheral blood mononuclear cell membrane sphingomyelin C14:0 and phosphatidylinositol C22:0. In the peripheral blood mononuclear cell membranes, C22:0 and C24:0 showed positive correlations, while C14:0, C16:0 and C20:0 showed inverse correlations with the Functional System Scores. In conclusion, this study is in accordance with previous studies that have shown an increase in shorter long-chain SATS in MS patients. In addition, this study also showed that higher C14:0 and C16:0 reflected better disease outcome as demonstrated by the inverse correlation with the EDSS and FSS. We have also characterized the specific SATS, that is, long-chain SATS that may increase the risk of developing MS.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19890702     DOI: 10.1007/s11011-009-9159-0

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  31 in total

1.  EPIDEMIOLOGIC STUDY OF MULTIPLE SCLEROSIS IN ISRAEL. I. AN OVERALL REVIEW OF METHODS AND FINDINGS.

Authors:  A ANTONOVSKY; U LEIBOWITZ; H A SMITH; J M MEDALIE; M BALOGH; R KATS; L HALPERN; M ALTER
Journal:  Arch Neurol       Date:  1965-08

Review 2.  Antioxidants and polyunsaturated fatty acids in multiple sclerosis.

Authors:  M E van Meeteren; C E Teunissen; C D Dijkstra; E A F van Tol
Journal:  Eur J Clin Nutr       Date:  2005-12       Impact factor: 4.016

3.  Design, synthesis, antibacterial, and QSAR studies of myristic acid derivatives.

Authors:  Balasubramanian Narasimhan; Vishnukant Mourya; Avinash Dhake
Journal:  Bioorg Med Chem Lett       Date:  2006-03-22       Impact factor: 2.823

4.  Epidemiological study of multiple sclerosis in western Poland.

Authors:  W Cendrowski; M Wender; W Dominik; Z Flejsierowicz; M Owsianowski; M Popiel
Journal:  Eur Neurol       Date:  1969       Impact factor: 1.710

5.  Deficiencies of polyunsaturated fatty acids and replacement by nonessential fatty acids in plasma lipids in multiple sclerosis.

Authors:  R T Holman; S B Johnson; E Kokmen
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

6.  Multiple sclerosis: an immune legacy?

Authors:  R L Cooper
Journal:  Med Hypotheses       Date:  1997-10       Impact factor: 1.538

Review 7.  Saturated fats: what dietary intake?

Authors:  J Bruce German; Cora J Dillard
Journal:  Am J Clin Nutr       Date:  2004-09       Impact factor: 7.045

8.  Immune cell membrane fatty acids and inflammatory marker, C-reactive protein, in patients with multiple sclerosis.

Authors:  Gloudina Hon; Mogamat Hassan; Susan Janse van Rensburg; Stefan Abel; De Wet Marais; Paul van Jaarsveld; Cornelius Smuts; Franclo Henning; Rajiv Erasmus; Tandi Matsha
Journal:  Br J Nutr       Date:  2009-05-19       Impact factor: 3.718

9.  Red blood cell fatty acids in multiple sclerosis.

Authors:  X Navarro; R Segura
Journal:  Acta Neurol Scand       Date:  1989-01       Impact factor: 3.209

10.  A comparison of composition and fluidity of multiple sclerosis and normal myelin.

Authors:  J M Boggs; M A Moscarello
Journal:  Neurochem Res       Date:  1980-03       Impact factor: 3.996

View more
  4 in total

1.  Cardiovascular profile improvement during Natalizumab treatment.

Authors:  Marcello Moccia; Roberto Albero; Roberta Lanzillo; Francesco Saccà; Anna De Rosa; Cinzia Valeria Russo; Antonio Carotenuto; Raffaele Palladino; Vincenzo Brescia Morra
Journal:  Metab Brain Dis       Date:  2017-12-18       Impact factor: 3.584

Review 2.  Fatty acids role in multiple sclerosis as "metabokines".

Authors:  Haojun Yu; Shuwei Bai; Yong Hao; Yangtai Guan
Journal:  J Neuroinflammation       Date:  2022-06-17       Impact factor: 9.587

3.  Red blood cell membrane fluidity in the etiology of multiple sclerosis.

Authors:  Gloudina M Hon; Mogamat S Hassan; Susan J van Rensburg; Stefan Abel; Paul van Jaarsveld; Rajiv T Erasmus; Tandi Matsha
Journal:  J Membr Biol       Date:  2009-11-14       Impact factor: 1.843

Review 4.  Metabolomic Biomarkers of Multiple Sclerosis: A Systematic Review.

Authors:  Lachlan Porter; Alireza Shoushtarizadeh; George A Jelinek; Chelsea R Brown; Chai K Lim; Alysha M de Livera; Kelly R Jacobs; Tracey J Weiland
Journal:  Front Mol Biosci       Date:  2020-12-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.